✦ LIBER ✦

Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancer

✍ Scribed by Kaneda, Hiroyasu; Tamura, Kenji; Kurata, Takayasu; Uejima, Hisao; Nakagawa, Kazuhiko; Fukuoka, Masahiro

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive factors associated with prolo

✍ Satouchi, M; Negoro, S; Funada, Y; Urata, Y; Shimada, T; Yoshimura, S; Kotani, Y 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

Risk factors for interstitial lung disea

✍ Takano, Toshimi; Ohe, Yuichiro; Kusumoto, Masahiko; Tateishi, Ukihide; Yamamoto, 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Factors associated with long-term surviv

✍ ETIENNE GIROUX LEPRIEUR; ARMELLE LAVOLE; ANNE-MARIE RUPPERT; VALéRIE GOUNANT; MA 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Clinicopathologic Factors Affecting the

✍ Katsuhiro Masago; Shiro Fujita; Yosuke Togashi; Young Hak Kim; Yukimasa Hatachi; 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 135 KB

Skin manifestations of gefitinib and the

✍ Shiou-Han Wang; Chih-Hsin Yang; Hsien-Ching Chiu; Fu-Chang Hu; Chih-Chieh Chan; 📂 Article 📅 2011 🏛 Medknow Publications 🌐 Chinese ⚖ 680 KB

PD-146 Clinical predictive factors, AKT

✍ Kang, J.; Kim, J.; Shin, J.; Im, S.; Lee, Y.; Lee, M.; Woo, I.; Lee, K.; Kim, S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB